Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

4 Defense Stocks To Buy As North Korea Ramps Up Weapons Test

Published 08/14/2019, 08:53 AM
Updated 07/09/2023, 06:31 AM
NOC
-
LMT
-
LDOS
-
AJRD
-

North Korea’s missile test on Aug 10 once again flared up the longstanding tension between the United States and North Korea. The latest firing is the fifth short-range missile test that the country has carried out since Jul 25.

While it is not a comforting news as far as the nations’ socio-political ties are concerned, major U.S. defense contractors have reason to cheer as the conflict may boost demand for weaponries.

Rationale Behind the Weapons Testing

Cross-border tensions between the United States and North Korea hit headlines in the recent past, particularly in the past couple of years. Both the nations have conducted counter missile tests. However, a settlement agreement of denuclearization signed by U.S. President Donald Trump and his North Korean counterpart Kim Jong-Un in Singapore, in June 2018, brought some relief.

To everyone’s surprise, the two primary aspects of the agreement were Jong-Un’s renewed commitment to complete denuclearization of the Korean Peninsula and Trump’s promise to pull out thousands of troops stationed in South Korea. Nevertheless, the recent revelation that the U.S. and South Korean militaries are planning to carry out a joint exercise in August reignited tensions between America and North Korea.

North Korea justified its recent act of consecutive missile tests as a means to put pressure on Seoul and Washington to stop such joint drills, which it presumably sees as a breach of last year’s agreement. In fact, per a report by Reuters, Pyongyang has accused Washington of breaking its promise by planning the military exercises and warned that the drills could derail talks of denuclearization.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Will Defense Stocks Gain?

The series of missile tests by North Korea threatens America’s security and the country may respond with counter missile tests and other tactical weaponries, thereby offering a solid impetus to a number of U.S. defense majors.

Analysts expect more such missile tests by North Korea in the coming days in a bid to keep Washington under pressure, which, in turn, would keep the tension alive in the Korean Peninsula that has been brewing over the past couple of weeks. Moreover, North Korea has not showed any intent in terms of progressing with denuclearization. So, any near-term improvement in the relations between these two nations is highly unlikely.

Our Picks

U.S. defense bellwethers are poised to benefit from the rising geopolitical tensions as the government will look to strengthen its arsenal. Considering this, we have selected five defense primes that have witnessed share price increase since Jul 25. These players also boast a favorable Zacks Rank and other fundamentals.

Northrop Grumman’s (NYSE:NOC) shares have risen 4.5%. This Zacks Rank #2 (Buy) company has a long-term earnings growth rate of 12.4%. The Zacks Consensus Estimate for its current-year earnings has increased 1.6% over the last 90 days.

Aerojet Rocketdyne’s (NYSE:AJRD) shares have gained 11.6%. This Zacks Rank #1 (Strong Buy) stock boasts a long-term earnings growth rate of 5.5%. The Zacks Consensus Estimate for current-year earnings increased 13.8% over the last 90 days. You can see the complete list of today’s Zacks #1 Rank stocks here.

Lockheed Martin’s (NYSE:LMT) shares have returned 1.9%. This Zacks Rank #2 company has a long-term earnings growth rate of 7.1%. The Zacks Consensus Estimate for its current-year earnings increased 3.8% over the last 90 days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Leidos Holdings’ (NYSE:LDOS) shares have gained 3.9%. This Zacks Rank #1 company has a long-term earnings growth rate of 7.5%. The Zacks Consensus Estimate for its current-year earnings increased 2.2% over the last 90 days.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



Leidos Holdings, Inc. (LDOS): Free Stock Analysis Report

Lockheed Martin Corporation (LMT): Free Stock Analysis Report

Northrop Grumman Corporation (NOC): Free Stock Analysis Report

Aerojet Rocketdyne Holdings, Inc. (AJRD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.